4//SEC Filing
INOTEK PHARMACEUTICALS CORP 4
Accession 0000899243-16-016568
$RCKTCIK 0001281895operating
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 8:49 PM ET
Size
6.3 KB
Accession
0000899243-16-016568
Insider Transaction Report
Form 4
McVicar William K.
See Remarks
Transactions
- Award
Stock Options (Right to Buy)
2016-03-22+135,000→ 135,000 totalExercise: $7.56Exp: 2026-03-21→ Common Stock (135,000 underlying)
Footnotes (2)
- [F1]The stock option award was issued pursuant to Inotek Pharmaceuticals Corporation's 2014 Stock Option and Incentive Plan (the "Plan"). 25% of the options granted shall vest on the one year anniversary of January 1, 2016 and 1/36th of the remaining option grant shall vest on each monthly anniversary thereafter, subject to continued service through such dates.
- [F2]As previously reported on June 26, 2015, the Reporting Person was granted a stock option award under the Plan. The total beneficially owned derivative securities following the grant inadvertently included securities of a separate class, and accordingly such previously inadvertently reported shares are now properly excluded. In addition, the Price of Derivative Security reported on the June 26, 2015 Form 4 was inadvertently reported as $5.03 when it should have properly been recorded as $0.
Documents
Issuer
INOTEK PHARMACEUTICALS CORP
CIK 0001281895
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001281895
Filing Metadata
- Form type
- 4
- Filed
- Mar 23, 8:00 PM ET
- Accepted
- Mar 24, 8:49 PM ET
- Size
- 6.3 KB